Enrolls Initial Patients for First-in-Human CoreoGraft Study

Hancock Jaffe Enrolls Initial Patients for First-in-Human CoreoGraft Study

Interim results for patients in the CoreoGraft study, which will take place at Italian Hospital Asuncion in Paraguay, will be available 30 days, 90 days, 180 days, and 365 days post-surgery.

finance.yahoo.com/ne...ients-150000419.html